| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/30/2010 | US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses |
| 09/30/2010 | US20100249029 Peptides with high affinity for the prolactin receptor |
| 09/30/2010 | US20100249026 Albumin fusion proteins |
| 09/30/2010 | US20100249025 Peptide antagonists of vascular endothelial growth factor |
| 09/30/2010 | US20100249022 Strategy for cloning and expressing the extracellular domains of receptors as soluble proteins |
| 09/30/2010 | US20100249021 Method and medicament for inhibiting the infection of influenza virus |
| 09/30/2010 | US20100248991 Solid support for high-throughput nucleic acid analysis |
| 09/30/2010 | US20100248990 siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2) |
| 09/30/2010 | US20100248988 High Throughput Screening Assay for the TRPM5 Ion Channel |
| 09/30/2010 | US20100248978 Method for identifying the interaction partner of an active agent |
| 09/30/2010 | US20100248976 G-protein coupled receptor kinase-5 polymorphism |
| 09/30/2010 | US20100248972 Enhanced Expression Method |
| 09/30/2010 | US20100248385 Multi-acceptor molecular probes and applications thereof |
| 09/30/2010 | US20100248364 SENSE OLOGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 09/30/2010 | US20100248363 Matrices and media for storage and stabilization of biomolecules |
| 09/30/2010 | US20100248360 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 09/30/2010 | US20100248359 Anti-Glypican 3 Antibody |
| 09/30/2010 | US20100248356 hTERT GENE EXPRESSION REGULATORY GENE |
| 09/30/2010 | US20100248336 Methods for purifying nucleic acids |
| 09/30/2010 | US20100248327 Cytochrome p450 oxygenases |
| 09/30/2010 | US20100248312 Alanine 2,3-aminomutases and related polynucleotides |
| 09/30/2010 | US20100248309 Thermostable alpha1-antitrypsin mutein with a disulfide bond and the method for preparing it |
| 09/30/2010 | US20100248307 Peptide production method |
| 09/30/2010 | US20100248305 Polyamino acid synthetase and gene encoding the same |
| 09/30/2010 | US20100248267 Method for measurement of concentration of antigen |
| 09/30/2010 | US20100248255 Novel peptides |
| 09/30/2010 | US20100248244 Characterization of ESM-1 as a Tumor Associated Marker of Colorectal Cancer |
| 09/30/2010 | US20100248240 Gene and protein relating to hepatocellular carcinoma and methods of use thereof |
| 09/30/2010 | US20100248234 Cancer diagnostic kit and cancer diagnostic method |
| 09/30/2010 | US20100248231 High specificity and high sensitivity detection based on steric hindrance & enzyme-related signal amplification |
| 09/30/2010 | US20100248222 Method of forming signal probe-polymer |
| 09/30/2010 | US20100248220 Chlamydia Trachomatis Specific Oligonucleotide Sequences |
| 09/30/2010 | US20100248218 Conjugates, and use thereof in detection methods |
| 09/30/2010 | US20100247662 Biologic Modulations with Nanoparticles |
| 09/30/2010 | US20100247657 Telomerase reverse transcriptase variant |
| 09/30/2010 | US20100247621 Codon modified immunogenic compositions and methods of use |
| 09/30/2010 | US20100247618 Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
| 09/30/2010 | US20100247578 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 09/30/2010 | US20100247576 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof |
| 09/30/2010 | US20100247560 Mutant botulinum neurotoxin serotype a polypeptide and uses thereof |
| 09/30/2010 | US20100247559 West nile virus vaccine, and method for production thereof |
| 09/30/2010 | US20100247558 PEPTIDES INDUCING A CD4i CONFORMATION IN HIV gp120 WHILE RETAINING VACANT CD4 BINDING SITE |
| 09/30/2010 | US20100247553 Goodpasture Antigen Binding Protein |
| 09/30/2010 | US20100247546 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/30/2010 | US20100247545 Antibodies to m-csf |
| 09/30/2010 | US20100247531 Anti-fgfr3 antibodies and methods using same |
| 09/30/2010 | US20100247530 Compositions and methods for preventing and treating presbycusis |
| 09/30/2010 | US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 09/30/2010 | US20100247517 Use of mnk inhibitors for the treatment of alzheimer's disease |
| 09/30/2010 | US20100247509 Fusion Proteins |
| 09/30/2010 | US20100247497 Vector particles for targetng cd34+ cells |
| 09/30/2010 | US20100247490 SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38 |
| 09/30/2010 | US20100247481 Abcb1 genotyping to predict microtubule-stabilizing-agent-induced toxicity |
| 09/30/2010 | US20100247442 Macaca fascicularis ST2L |
| 09/30/2010 | US20100243451 Pcr methods for characterizing the 5' untranslated region of the fmr1 and fmr2 genes |
| 09/30/2010 | DE102009015978A1 Verfahren zur Bestimmung der Prädisposition eines Patienten zu veränderter Biotransformation und zur Entwicklung von unerwünschten Arzneimittelwirkungen bei einer Behandlung des Patienten mit Atorvastatin Method for determining the predisposition of a subject to altered biotransformation and the development of adverse drug reactions in a treatment of the patient with atorvastatin |
| 09/30/2010 | CA2755799A1 Method and apparatus for predicting susceptibility to a developmental disorder |
| 09/29/2010 | EP2233573A1 A complex molecule interfering the expression of target genes and its preparing methods |
| 09/29/2010 | EP2233567A1 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| 09/29/2010 | EP2233494A1 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 09/29/2010 | EP1984381B1 6-modified bicyclic nucleic acid analogs |
| 09/29/2010 | EP1692159B1 Tgf-beta1 binding and supported peptides |
| 09/29/2010 | EP1572952B1 Novel polynucleotide and polypeptide sequences and uses thereof |
| 09/29/2010 | CN1878785B Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
| 09/29/2010 | CN101849020A Riboswitches and methods and compositions for use of and with riboswitches |
| 09/29/2010 | CN101849004A Use of iridoptin to induce toxicity in insects |
| 09/29/2010 | CN101848924A Gene knockout mesophilic and thermophilic organisms, and methods of use thereof |
| 09/29/2010 | CN101848923A Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 09/29/2010 | CN101845071A Nucleoside derivative of 2' or 3' coupling amino acid, preparation method and application thereof |
| 09/29/2010 | CN101215561B MiR-181a antisense oligonucleotide with leukemia resisting action and application thereof |
| 09/29/2010 | CN101215560B MiR-21 antisense oligonucleotide with leukemia resisting action and application thereof |
| 09/28/2010 | US7804012 Inbred sweet corn line R605 |
| 09/28/2010 | US7803989 KCP-like nucleic acids coding polypeptide for use in the generation of disease resistant plants; host cell; plant is maize, soybean, sunflower, sorghum, canola, wheat, alfalfa, cotton, rice, barley, or millet |
| 09/28/2010 | US7803943 Use of bridged nucleic acid fluorescent dyes, such as phenanthridinium dyes, cyanine dyes, or acridinium dyes each having an ammonium group and anion; bridging group can be -CH2-CONH-(CH2-CH2-O)x-(CH2)2-NHCO-CH2- ; low background fluorescence in the absence of nucleic acids; noncarcinogenic, stability |
| 09/28/2010 | US7803935 using biscationic organic compounds which promote adsorption of nucleic acids from an aqueous solution to a solid phase such as silica; for purifying a nucleic acid |
| 09/28/2010 | US7803934 Parallel preparation of high fidelity probes in an array format |
| 09/28/2010 | US7803933 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 09/28/2010 | US7803932 Compositions and methods for inhibiting EB-1-mediated microtubule stability |
| 09/28/2010 | US7803931 aptamer PEG conjugate; transplant rejection; angioplasty; restenosis; specificity and affinity of the aptamer can be tightly controlled and allows the generation of leads; no toxicity or immunogenicity; chemical stability |
| 09/28/2010 | US7803930 Antisense modulation of apolipoprotein B-expression |
| 09/28/2010 | US7803929 Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urine |
| 09/28/2010 | US7803925 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells |
| 09/28/2010 | US7803924 Polynucleotide encoding a protein that is highly immunogenic especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens |
| 09/28/2010 | US7803922 Expression vector comprising nucleotide sequences coding cleavage enzyme for use in gene expression profiling |
| 09/28/2010 | US7803921 For determining if a mammal is predisposed to cancer, nucleic acid molecule; vectors; substrate comprising the isolated nucleic acid molecule |
| 09/28/2010 | US7803920 ECAT16 gene expressed specifically in ES cells and utilization of the same |
| 09/28/2010 | US7803919 Bovine ABCG2 gene missense mutations and uses thereof |
| 09/28/2010 | US7803918 gene delivery vehicle comprising the isolated and/or recombinant nucleic acid sequence; methods for typing the virus in various samples and diagnosing of disease |
| 09/28/2010 | US7803908 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 09/28/2010 | US7803905 Comprises genetically engineered matrix proteins immobilized on solid support for implantation, repair and treatment of bone disorders |
| 09/28/2010 | US7803788 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 09/28/2010 | US7803784 Modulation of T cell signaling threshold and T cell sensitivity to antigens |
| 09/28/2010 | US7803781 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/28/2010 | US7803622 Adeno-associated virus vectors |
| 09/28/2010 | US7803620 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms Shewanella japonica and Shewanella olleyana; plants and microorganisms that produce lipids |
| 09/28/2010 | US7803612 Nipah virus vaccines |
| 09/28/2010 | US7803611 RNAi expression constructs |
| 09/28/2010 | US7803603 Nematode ATP synthase subunit E polypeptide |
| 09/28/2010 | US7803598 CGTase polypeptide with increased hydrolase activity; useful in preparing a food or a food product such as bakery products |
| 09/28/2010 | US7803597 Thermally-tolerant pectin methylesterase |